Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Effects of rTMS and Botulinum Toxin in Benign Essential Blepharospasm: A Novel Approach

NCT02370875 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT02370875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02370875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Effects of rTMS and Botulinum Toxin in Benign Essential Blepharospasm: A Novel Approach
Lead sponsor
University of Florida
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2015
Completion date
November 30, 2017
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign essential blepharospasm